NN Investment Partners Holdings’s Bristol-Myers Squibb BMY Stock Holding History

NN Investment Partners Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$89.7M	Buy	1,228,935 +313,621	+34%	+$21.1M	0.48%	46
2021 Q4	$57.1M	Buy	915,314 +149,803	+20%	+$8.79M	0.29%	62
2021 Q3	$45.3M	Sell	765,511 -18,094	-2%	-$1.19M	0.25%	76
2021 Q2	$52.4M	Sell	783,605 -50,924	-6%	-$3.32M	0.28%	67
2021 Q1	$52.7M	Buy	834,529 +92,932	+13%	+$5.78M	0.31%	60
2020 Q4	$46M	Sell	741,597 -70,772	-9%	-$4.35M	0.28%	70
2020 Q3	$49M	Buy	812,369 +10,060	+1%	+$605K	0.32%	62
2020 Q2	$47.2M	Buy	802,309 +57,988	+8%	+$3.47M	0.32%	60
2020 Q1	$41.5M	Sell	744,321 -224,841	-23%	-$13.7M	0.34%	60
2019 Q4	$62.2M	Buy	969,162 +323,527	+50%	+$18.5M	0.42%	50
2019 Q3	$32.7M	Sell	645,635 -209,281	-24%	-$9.84M	0.26%	85
2019 Q2	$38.8M	Sell	854,916 -652,924	-43%	-$30.4M	0.31%	69
2019 Q1	$71.9M	Sell	1,507,840 -137,184	-8%	-$6.83M	0.56%	38
2018 Q4	$85.5M	Buy	1,645,024 +153,411	+10%	+$8.24M	0.72%	28
2018 Q3	$92.6M	Buy	1,491,613 +154,038	+12%	+$9.14M	0.67%	31
2018 Q2	$74M	Buy	1,337,575 +249,848	+23%	+$13.5M	0.54%	44
2018 Q1	$68.8M	Sell	1,087,727 -457,925	-30%	-$29.5M	0.49%	49
2017 Q4	$94.7M	Buy	1,545,652 +28,651	+2%	+$1.79M	0.67%	39
2017 Q3	$96.7M	Sell	1,517,001 -64,453	-4%	-$3.76M	0.62%	44
2017 Q2	$88.1M	Buy	1,581,454 +802,931	+103%	+$43.7M	0.81%	34
2017 Q1	$42.3M	Buy	778,523 +362,097	+87%	+$19.9M	0.4%	69
2016 Q4	$24.3M	Buy	416,426 +33,878	+9%	+$1.85M	0.23%	117
2016 Q3	$20.6M	Sell	382,548 -687,225	-64%	-$44.1M	0.19%	125
2016 Q2	$78.7M	Sell	1,069,773 -22,558	-2%	-$1.59M	0.74%	37
2016 Q1	$69.8M	Buy	+1,092,331	New	+$68.9M	0.67%	39

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

NN Investment Partners Holdings's BMY Position: Q1 2022 in Review

NN Investment Partners Holdings increased its Bristol-Myers Squibb (BMY) stake by 34% in Q1 2022, buying an estimated $21.1M and bringing the position to 1,228,935 shares worth $89.7M. The position accounts for 0.48% of the portfolio, ranked #46.

NN Investment Partners Holdings first reported a position in BMY in Q1 2016 and has held it in 25 quarters since. The position peaked at $96.7M in Q3 2017. 2,516 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

NN Investment Partners Holdings held 1,228,935 shares of Bristol-Myers Squibb worth $89.7M as of Q1 2022.
NN Investment Partners Holdings bought 313,621 Bristol-Myers Squibb shares in Q1 2022, an estimated $21.1M.
Bristol-Myers Squibb made up 0.48% of NN Investment Partners Holdings's portfolio in Q1 2022, its #46 holding.
NN Investment Partners Holdings first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 25 quarters since.
NN Investment Partners Holdings's Bristol-Myers Squibb position peaked at $96.7M in Q3 2017.
2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.